Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,531,011
-$70,084,917 QoQ
Shares Held
876,970
-55.9% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
2.70%
of 13F equity value
Holder Rank
#170
of 2,514 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sofinnova Investments, Inc. holds $93,878,265 across 2 Drug Manufacturers - General names. BMY ranks #1 (53.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
This page
|
876,970 | $50,531,011 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
343,100 | $43,347,254 |
All Filings in BMY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,531,011 | 876,970 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $120,615,928 | 1,988,721 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $81,610,896 | 1,512,994 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $22,657,602 | 371,497 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||